Travere Therapeutics, Inc.

TVTX - Company ID 0001438533

Market cap$5.44 B

Rank#1355

Filings1,232

Travere Therapeutics, Inc. has filed 1,232 public company documents between 2008 and 2026. The most frequent type is insider trade (504 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchTVTX overview$5.44 BMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyRank #1355See the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with LLYPeer viewPut TVTX beside LLY across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow TVTX via RSS

Similar companies to research next

LLYEli Lilly and Company

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
S-8	Employee stock plan	1y ago2025-06-17	-	View filing
S-8	Employee stock plan	2y ago2024-06-14	-	View filing
S-8	Employee stock plan	2y ago2023-08-03	-	View filing
S-8	Employee stock plan	3y ago2022-08-18	-	View filing
S-8	Employee stock plan	4y ago2021-07-29	-	View filing
S-8	Employee stock plan	5y ago2020-07-31	-	View filing
S-8	Employee stock plan	6y ago2019-07-26	-	View filing
S-8	Employee stock plan	8y ago2018-05-11	-	View filing
S-8	Employee stock plan	9y ago2017-06-08	-	View filing
S-8	Employee stock plan	9y ago2016-09-13	-	View filing
S-8	Employee stock plan	10y ago2015-08-21	-	View filing
S-8	Employee stock plan	11y ago2014-11-14	-	View filing

Travere Therapeutics, Inc.

Similar companies to research next

Year